AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 8901143
Drug: Oral aqueous
RxNorm normalized name: Pen-Aqueous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral aqueous solution of chlorprothixene (100 mg)
Trial: 8901143
Drug: Coated tablet
RxNorm normalized name: COATED TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coated tablet of chlorprothixene (100 mg)
Trial: 8901143
Drug: Suspension of
RxNorm normalized name: Suspension of heat killed (autoclaved) Mycobacterium w
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suspension of chlorprothixene (100 mg)
Trial: 21840651
Drug: 350 mg
RxNorm normalized name: hemin 350 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 350 mg carisoprodol
Trial: 21840651
Drug: 350 mg
RxNorm normalized name: hemin 350 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 350 mg carisoprodol followed by 10 mg oxycodone after 60 min
Trial: 19703819
Drug: Clopidogrel (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel (75 mg) plus atorvastatin (10 mg) daily for 6 months
Trial: 19703819
Drug: Aspirin (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (300 mg) plus atorvastatin (10 mg) daily for 6 months
Trial: 9042316
Drug: Methioninase (5,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methioninase (5,000 units, 2-hour infusion)
Trial: 9042316
Drug: Methioninase (10,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methioninase (10,000 units, 2-hour infusion)
Trial: 9042316
Drug: Methioninase (20,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methioninase (20,000 units, 10-hour infusion)
Trial: 6147066
Drug: Basal therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basal therapy (standardized information, self-exposure instructions, and anxiolytic medication)
Trial: 21470906
Drug: Interactive e-drug
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interactive e-drug calculations package
Trial: 10685748
Drug: Braintree polyethylene
RxNorm normalized name: polyethylenes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Braintree polyethylene glycol (PEG) laxative 17 g
Trial: 9157586
Drug: rHDL (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rHDL (40 mg/kg, given as a 4 h infusion starting 3.5 h prior to LPS injection)
Trial: 3453715
Drug: Ketotifen 2
RxNorm normalized name: ketotifen 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketotifen 2 mg/d with desensitization
Trial: 3453715
Drug: Specific hyposensitization
RxNorm normalized name: Pacific halibut
DrugBank: Pacific halibut (DB10616)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specific hyposensitization treatment
Trial: 24047189
Drug: Echocardiographically guided
RxNorm normalized name: Autologous CD34+ cells isolated from mobilised peripheral blood by positive selection, modified by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) mediated gene editing consisting of a guide RNA (gRNA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Echocardiographically guided ibuprofen treatment
Trial: 24047189
Drug: Standard ibuprofen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard ibuprofen treatment
Trial: 22486722
Drug: BioCell Collagen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BioCell Collagen (BCC) 2 g
Trial: 20507953
Drug: Less intensive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Less intensive renal replacement therapy
Trial: 10480205
Drug: High-dose (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose (200 units Botox per leg)
Trial: 10480205
Drug: Low-dose (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose (100 units Botox per leg)
Trial: 8911559
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg paroxetine daily
Trial: 386715
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg imipramine daily
Trial: 7362377
Drug: Meperidine hydrochloride
RxNorm normalized name: Meperidine Hydrochloride
DrugBank: Meperidine (DB00454)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meperidine hydrochloride (45 mg)
Trial: 17613971
Drug: Outpatient Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Outpatient Treatment (OP)
Trial: 15462690
Drug: rosuvastatin 5
RxNorm normalized name: rosuvastatin 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rosuvastatin 5 mg and 10 mg
Trial: 9382964
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (0.1 IU x kg(‐1) x day(‐1)) for 4 days
Trial: 9382964
Drug: Glucocorticoid (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucocorticoid (50 mg/d) for 4 days
Trial: 9382964
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone plus glucocorticoid
Trial: 9382964
Drug: Control (saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (saline injections for 4 days)
Trial: 8390369
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg bisoprolol p.o. (pretreatment)
Trial: 8390369
Drug: 1200 mg
RxNorm normalized name: aspirin 1200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1200 mg celiprolol p.o.
Trial: 3548809
Drug: Hypo-osmolar formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypo-osmolar formulation using polyvinylpyrrolidone and hydroxyethyl cellulose
Trial: 3548809
Drug: Hypo-osmolar preparations
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypo-osmolar preparations of BJ6
Trial: 29986448
Drug: Shooters with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shooters with blood lead levels (BLL) ≥ 5 µg/dL
Trial: 24428468
Drug: ABT-450/r (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABT-450/r (150 mg of ABT-450 and 100 mg of ritonavir) plus ribavirin for 8 weeks
Trial: 24428468
Drug: ABT-450/r (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABT-450/r (150 mg of ABT-450 and 100 mg of ritonavir) plus ribavirin for 12 weeks
Trial: 24428468
Drug: All treatment
RxNorm normalized name: UNDECYLENIC ACID 8 g in 30 mL / TOLNAFTATE 1 g in 30 mL TOPICAL LIQUID [Fugal nall treatment]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All treatment subgroups (various regimens of direct-acting antiviral agents and ribavirin)
Trial: 22774206
Drug: Pazopanib 800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pazopanib 800 mg daily by mouth
Trial: 17712755
Drug: Isoniazid monotherapy
RxNorm normalized name: Isoniazid
DrugBank: Isoniazid (DB00951)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isoniazid monotherapy for 9 months (group A)
Trial: 16371678
Drug: Methylphenidate (usual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate (usual medication)
Trial: 31769998
Drug: Drug repurposing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug repurposing candidates identified through integration of pharmacodynamic and marketing variables from DrugBank and genomic data from BioVU.
Trial: 25363555
Drug: First-line therapy
RxNorm normalized name: varenicline
DrugBank: Varenicline (DB01273)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: First-line therapy (PPI-based triple therapy for seven days)
Trial: 25363555
Drug: Second-line therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Second-line therapy (moxifloxacin-based triple therapy or bismuth-based quadruple therapy)
Trial: 25363555
Drug: Third-line therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Third-line therapy (unused MA or QUAD)
Trial: 19738139
Drug: Empirical antiarrhythmic
RxNorm normalized name: ANTIARRHYTHMICS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empirical antiarrhythmic drug (AAD) therapy for 6 weeks after AF ablation
Trial: 19738139
Drug: No antiarrhythmic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No antiarrhythmic therapy (no-AAD group)
Trial: 19738139
Drug: Empirical antiarrhythmic
RxNorm normalized name: ANTIARRHYTHMICS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empirical antiarrhythmic drug (AAD) therapy
Trial: 17557041
Drug: High-dose proton
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose proton pump inhibitor (PPI) therapy
Trial: 7917776
Drug: Transdermal morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal morphine (10 mg)
Trial: 7917776
Drug: Intravenous morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous morphine (10 mg over 20 min)
Trial: 3045441
Drug: Lithium (Li)
DrugBank: Lithium succinate (DB14508)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lithium (Li) therapy
Trial: 23085153
Drug: Dutasteride 0.5mg
RxNorm normalized name: DUTASTERIDE 0.5MG CAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dutasteride 0.5mg daily for six months
Trial: 12784273
Drug: 2 ml
RxNorm normalized name: ethanol 2 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 ml of placebo injected into the parotids and submandibular glands
Trial: 11171715
Drug: Montelukast (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast (10 mg/d for 3 days)
Trial: 1554077
Drug: Conservative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative treatment of the anterior cruciate ligament
Trial: 4019257
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg ascorbic acid twice a day for 60 days
Trial: 23697585
Drug: LCn‐3PUFA (fish
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LCn‐3PUFA (fish oil) 6 × 1 g capsules/d
Trial: 23697585
Drug: Placebo (monounsaturated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (monounsaturated oil) 6 × 1 g capsules/d
Trial: 19489494
Drug: Surrounded needling
RxNorm normalized name: NEEDLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surrounded needling therapy
Trial: 19489494
Drug: Western medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medicine (Indomethacin and Allopurinol)
Trial: 17272406
Drug: Testosterone treatment
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone treatment (8-10 days)
Trial: 17272406
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment (8-10 days)
Trial: 17272406
Drug: Episodic hypoxia
RxNorm normalized name: Hypoxis hemerocallidea root extract
DrugBank: St. John's Wort (DB01323)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Episodic hypoxia (after treatment with testosterone or placebo)
Trial: 1679645
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg flumazenil
Trial: 1679645
Drug: Higher doses
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher doses of flumazenil (2-5 mg)
Trial: 7041850
Drug: Simple exercise
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simple exercise therapy
Trial: 6691783
Drug: CT plus
RxNorm normalized name: Protect Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CT plus pharmacotherapy
Trial: 28333879
Drug: Sustained Group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained Group (monthly IAI for 3 months, then every 2 months for 12 months)
Trial: 28333879
Drug: PRN Group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PRN Group (1 IAI at randomization, then monthly PRN IAI for 12 months)
Trial: 24161334
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy for both TI and CLI patients
Trial: 18545057
Drug: Citalopram (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram (10 mg/day, intravenous)
Trial: 12840614
Drug: Various treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Various treatment procedures including epidural steroids, trigger point injections, and cognitive-behaviorally oriented psychoeducational groups
Trial: 11142163
Drug: Continuous intraportal
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous intraportal 5-FU infusion
Trial: 11142163
Drug: UFT/LV (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UFT/LV (oral chemotherapy)
Trial: 8864039
Drug: Females using
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Females using oral contraceptives
Trial: 6361628
Drug: Nabumetone, 500
RxNorm normalized name: Nabumetone, 500 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nabumetone, 500 mg two nocte
Trial: 6361628
Drug: Naproxen, 250
RxNorm normalized name: Naproxen, 250 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen, 250 mg two nocte and one mane
Trial: 27596132
Drug: Icosapent ethyl
RxNorm normalized name: Icosapent Ethyl
DrugBank: Icosapent ethyl (DB08887)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Icosapent ethyl 2 g/day
Trial: 7560220
Drug: Normal oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal oral hygiene alone
Trial: 9408065
Drug: Picotamide (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Picotamide (300 mg b.i.d.)
Trial: 1834396
Drug: Low-dosage aspirin
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dosage aspirin (300 mg/die)
Trial: 7127989
Drug: Syringe for
RxNorm normalized name: Cimzia 200mg/mL Prefilled Syringe for Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Syringe for medication delivery
Trial: 7127989
Drug: Teaspoon for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Teaspoon for medication delivery
Trial: 20215488
Drug: Once-weekly gym-based
RxNorm normalized name: risedronate
DrugBank: Risedronic acid (DB00884)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Once-weekly gym-based exercise programme
Trial: 20215488
Drug: Twice-weekly gym-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice-weekly gym-based exercise programme
Trial: 15250255
Drug: Omega-3 fatty
RxNorm normalized name: Omega-3 fatty acid
DrugBank: Omega-3 fatty acids (DB11133)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omega-3 fatty acids (3 g/d)
Trial: 11236069
Drug: Pindolol 5
RxNorm normalized name: pindolol 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pindolol 5 mg three times a day
Trial: 9315414
Drug: 30 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 micrograms ethinyl estradiol and 2.00 mg dienogest
Trial: 29099421
Drug: Atorvastatin 20
RxNorm normalized name: atorvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 20 mg daily with propranolol
Trial: 26259978
Drug: Conventional pen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional pen injection of insulin aspart
Trial: 24050578
Drug: Placebo capsules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo capsules three times a day for two months
Trial: 21878082
Drug: fixed combination
RxNorm normalized name: Progestogens and estrogens, fixed combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: fixed combination amlodipine/valsartan
Trial: 15467597
Drug: Rabeprazole (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabeprazole (20 mg b.i.d.)
Trial: 19407662
Drug: Pantoprazole (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pantoprazole (40 mg b.i.d.)
Trial: 9210707
Drug: Combined immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined immunotherapy with IL-2 and LAK cells after chemotherapy or radiotherapy (Group A)
Trial: 9210707
Drug: Control standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control standard therapy (Group B)
Trial: 9210707
Drug: Combined immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined immunotherapy (Group A)
Trial: 2655683
Drug: Homoeopathic preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Homoeopathic preparation
Trial: 21415581
Drug: Dobutamine stress
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dobutamine stress echocardiography (DSE) at peak infusion (40 μg/kg/min)
Trial: 18721181
Drug: Proactive airway
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proactive airway clearance (AC) strategy, performed twice daily
Trial: 16669959
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy (aminosalicylates and weekly tapered corticosteroids)
Trial: 16669959
Drug: Heparin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin therapy (standard therapy plus enoxaparin 100 Anti‐Xa IU/kg/day subcutaneously)
Trial: 11728290
Drug: Candesartan cilexetil
RxNorm normalized name: Candesartan Cilexetil
DrugBank: Candesartan cilexetil (DB00796)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Candesartan cilexetil (16 mg once daily, titrated to 32 mg as needed, with hydrochlorothiazide 12.5 mg as needed)
Trial: 8126257
Drug: Misoprostol 800
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Misoprostol 800 mcg/day
Trial: 3110681
Drug: L-carnitine added
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-carnitine added to dialysis fluid at a final concentration of 100 mumol/l
Trial: 20587129
Drug: Real rTMS
RxNorm normalized name: REAL FOODS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Real rTMS treatment (n=14)
Trial: 20587129
Drug: Sham rTMS
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham rTMS treatment (n=14)
Trial: 18156403
Drug: Lycopene at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lycopene at a dose of 15 mg/d for 6 months
Trial: 3426370
Drug: Loperamide (Imodium)
RxNorm normalized name: loperamide Oral Capsule [Imodium]
DrugBank: Loperamide (DB00836)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Loperamide (Imodium) at an average dose of 20 to 25 drops/kg/24 h (0.16 to 0.20 mg/kg/24 h), given every 8 hours for at least 48 hours.
Trial: 29998815
Drug: Pre-operative analgesics
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pre-operative analgesics (paracetamol and ibuprofen)
Trial: 22542118
Drug: Treatment for
RxNorm normalized name: Hair Regrowth Treatment For Men
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Treatment for mild gestational diabetes mellitus
Trial: 20565484
Drug: Airsonett Airshower
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Airsonett Airshower (AA) treatment with allergen-free air during night sleep
Trial: 12641688
Drug: Morphine (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (0.1 mg.kg(‐1))
Trial: 12641688
Drug: Tramadol (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol (2 mg.kg(‐1))
Trial: 2005049
Drug: Minimal treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minimal treatment (control group)
Trial: 6193666
Drug: Admixture group:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Admixture group: 20 ml dextran 1, 15% (Promiten) mixed with 500 ml dextran 70 (Macrodex) or dextran 40 (Rheomacrodex)
Trial: 6193666
Drug: Preinjection group:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preinjection group: 20 ml dextran 1, 15% administered before the infusion of dextran 70 or 40
Trial: 27553442
Drug: PCFNB (bolus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PCFNB (bolus infusion of 3 ml with a lockout time of 30 min and no basal infusion)
Trial: 27553442
Drug: cFNB (basal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cFNB (basal infusion of 6 ml/h using a dummy bolus button)
Trial: 24132707
Drug: 8 mg
RxNorm normalized name: alloin 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg ondansetron film-coated tablets (test product)
Trial: 22263710
Drug: Methadone maintenance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methadone maintenance treatment (MMT) initiated prior to release from incarceration
Trial: 19021604
Drug: Single preoperative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single preoperative dose of ciprofloxacin (2 tablets of 500 mg each, 2 hours before biopsy)
Trial: 2802123
Drug: Propofol 2.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 2.15 mg/kg
Trial: 2802123
Drug: Thiopentone 4.53
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopentone 4.53 mg/kg
Trial: 345570
Drug: Oral iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral iron therapy for anaemic adult villagers
Trial: 345570
Drug: Oral iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral iron and/or TCE for children aged 5-14 years
Trial: 30707970
Drug: Genistein treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Genistein treatment
Trial: 26222559
Drug: ISIS 304801
RxNorm normalized name: ISIS-APOCIII-LRX
DrugBank: Olezarsen (DB18728)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ISIS 304801 (100 mg)
Trial: 26222559
Drug: ISIS 304801
RxNorm normalized name: ISIS-APOCIII-LRX
DrugBank: Olezarsen (DB18728)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ISIS 304801 (200 mg)
Trial: 26222559
Drug: ISIS 304801
RxNorm normalized name: ISIS-APOCIII-LRX
DrugBank: Olezarsen (DB18728)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ISIS 304801 (300 mg)
Trial: 26222559
Drug: ISIS 304801
RxNorm normalized name: ISIS-APOCIII-LRX
DrugBank: Olezarsen (DB18728)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ISIS 304801 (200 mg, add-on to fibrates)